Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;20(2):409-414.
doi: 10.1007/s42000-020-00259-x. Epub 2020 Nov 25.

The association of diabetes with COVID-19 disease severity: evidence from adjusted effect estimates

Xuan Liang  1 , Jie Xu  1 , Wenwei Xiao  1 , Li Shi  1 , Haiyan Yang  2
Affiliations

The association of diabetes with COVID-19 disease severity: evidence from adjusted effect estimates

Xuan Liang et al. Hormones (Athens). 2021 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Fig. 1
Fig. 1
The pooled odds ratio (OR) (a), hazard ratio (HR) (b), and their 95% confidence interval (CI) of the relationship between diabetes and the risk of disease severity in patients with COVID-19. Sensitivity analysis for evaluating the relationship between diabetes and the risk of disease severity in patients with COVID-19 (c)
See this image and copyright information in PMC

References

    1. Frydrych LM, Bian G, O’Lone DE, Ward PA, Delano MJ. Obesity and type 2 diabetes mellitus drive immune dysfunction, infection development, and sepsis mortality. J Leukoc Biol. 2018;104(3):525–534. doi: 10.1002/JLB.5VMR0118-021RR. - DOI - PubMed
    1. Palaiodimos L, Kokkinidis DG, Li W, Karamanis D, Ognibene J, Arora S, Southern WN, Mantzoros CS. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metab Clin Exp. 2020;108:154262. doi: 10.1016/j.metabol.2020.154262. - DOI - PMC - PubMed
    1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England) 2020;395(10223):497–506. doi: 10.1016/s0140-6736(20)30183-5. - DOI - PMC - PubMed
    1. Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, Li Q, Jiang C, Zhou Y, Liu S, Ye C, Zhang P, Xing Y, Guo H, Tang W (2020) Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 10.1016/j.jinf.2020.04.021 - PMC - PubMed
    1. Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM, Aaron JG, Claassen J, Rabbani LE, Hastie J, Hochman BR, Salazar-Schicchi J, Yip NH, Brodie D, O'Donnell MR. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395(10239):1763–1770. doi: 10.1016/s0140-6736(20)31189-2. - DOI - PMC - PubMed